Health -
Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information
Company Provides New 2016 Guidance LAVAL, Quebec, March 15, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the […]